NDAQ
39
-3
R
54
-2
SIG
55
-3
JBHT
38
-2
HAS
46
6
RCL
61
-8
SPG
56
-5
AXP
60
3
RL
76
-3
PRGO
39
-3
NTAP
66
-8
EQT
34
-5
PNW
46
-2
GILD
29
-7
MRO
32
-14
ORLY
53
3
PSA
55
2
LMT
39
-3
HPQ
57
-5
EMN
65
-4
NDAQ
39
-3
R
54
-2
SIG
55
-3
JBHT
38
-2
HAS
46
6
RCL
61
-8
SPG
56
-5
AXP
60
3
RL
76
-3
PRGO
39
-3
NTAP
66
-8
EQT
34
-5
PNW
46
-2
GILD
29
-7
MRO
32
-14
ORLY
53
3
PSA
55
2
LMT
39
-3
HPQ
57
-5
EMN
65
-4
Financhill
Back

Can Fite Biofarma Vs. XTL Biopharmaceuticals Industry Stock Comparison

Buy
59

CANF
Can Fite Biofarma

Last Price:
3.45
Seasonality Move:
-6.47%
Sell
30

XTLB
XTL Biopharmaceuticals

Last Price:
2.07
Seasonality Move:
0.3%
Buy
59
Can Fite Biofarma (CANF) is a Buy

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $3.35. The Score for CANF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CANF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy, Sell or Hold?

  • The current XTL Biopharmaceuticals [XTLB] share price is $2.04. The Score for XTLB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • XTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $3.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.

XTLB Stock Price Chart

What is XTL Biopharmaceuticals's stock price today?

  • The XTL Biopharmaceuticals share price today is $2.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing selling pressure, which indicates risk of future bearish movement.

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 70.81 Buy
Chaikin Money Flow: -431492 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.14 - 2.88) Buy
Bollinger Bands (100): (1.94 - 2.48) Buy

XTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 34.23 Sell
Chaikin Money Flow: -6963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.28 - 2.74) Sell
Bollinger Bands (100): (1.08 - 2.8) Buy

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.88 Buy
20-day SMA: 2.61 Buy
50-day SMA: 2.3 Buy
200-day SMA: 2.23 Buy
8-day EMA: 3 Buy
20-day EMA: 2.68 Buy
50-day EMA: 2.42 Buy
200-day EMA: 2.49 Buy

XTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.21 Sell
20-day SMA: 2.46 Sell
50-day SMA: 2.57 Sell
200-day SMA: 1.45 Buy
8-day EMA: 2.21 Sell
20-day EMA: 2.37 Sell
50-day EMA: 2.37 Sell
200-day EMA: 1.72 Buy

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.

XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

XTL Biopharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):